Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | KLK7 | P49862 | 1/20 | 0.36 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.36 |
| ▸ | CDC25B | P30305 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31246231 | 0.84 | SMYD2 (0.39) | — | |
| SCHEMBL14296506 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MAPK1L3MBTL1ATM | |
| SCHEMBL17268485 | 0.81 | LTA4H (0.42) | SLC15A1ALDH1A1 | |
| SCHEMBL9956224 | 0.80 | ALDH1A1 (0.49) | ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL6496823 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL29627016 | 0.80 | FAAH (0.49) | ALDH1A1L3MBTL1 | |
| SCHEMBL23485565 | 0.79 | RAB9A (0.40) | ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL23455745 | 0.78 | ITGB3 (0.50) | ALDH1A1ATM | |
| SCHEMBL23455744 | 0.78 | ITGB3 (0.50) | ALDH1A1ATM | |
| SCHEMBL23485563 | 0.78 | ABCB1 (0.36) | ALDH1A1MAPK1L3MBTL1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713320-A2 | BCAT2 INHIBITORS | Agios Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238820-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |